Vera Therapeutics (VERA) Enterprise Value (2020 - 2026)
Vera Therapeutics posted quarterly Enterprise Value of -$596.8 million for Q1 2026, down 1.17% year-on-year from -$603.9 million in Q1 2025, and up 16.49% on a QoQ basis from -$714.6 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Enterprise Value data on file, last reported at -$596.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 1.17% year-over-year to -$596.8 million; the trailing twelve-month figure through Mar 2026 stood at -$596.8 million (down 1.17% YoY), and the FY2025 full-year result was -$714.6 million, down 11.51% from the prior year.
- Enterprise Value for Q1 2026 stood at -$596.8 million, up from -$714.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$114.4 million in Q3 2022 and bottomed at -$714.6 million in Q4 2025.
- The 5-year median for Enterprise Value is -$353.3 million (2024), against an average of -$349.9 million.
- The widest annual swing landed in 2024, when Enterprise Value sank 298.75%; it then slipped 1.17% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$114.7 million in 2022, then plunged by 40.18% to -$160.7 million in 2023, then tumbled by 298.75% to -$640.9 million in 2024, then slipped by 11.51% to -$714.6 million in 2025, then gained by 16.49% to -$596.8 million in 2026.
- The last three Enterprise Value figures came in at -$596.8 million (Q1 2026), -$714.6 million (Q4 2025), and -$497.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -596.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -596.76 Mn |
| Dec 31, 2025 | -714.59 Mn |
| Sep 30, 2025 | -497.39 Mn |
| Jun 30, 2025 | -556.83 Mn |
| Mar 31, 2025 | -589.83 Mn |
| Dec 31, 2024 | -640.85 Mn |
| Sep 30, 2024 | -353.31 Mn |
| Jun 30, 2024 | -384.39 Mn |
| Mar 31, 2024 | -403.66 Mn |
| Dec 31, 2023 | -160.72 Mn |
| Sep 30, 2023 | -159.94 Mn |
| Jun 30, 2023 | -181.02 Mn |
| Mar 31, 2023 | -197.15 Mn |
| Dec 31, 2022 | -114.65 Mn |
| Sep 30, 2022 | -114.42 Mn |
| Jun 30, 2022 | -131.93 Mn |
| Mar 31, 2022 | -150.94 Mn |
| Dec 31, 2021 | -79.67 Mn |
| Sep 30, 2021 | -86.25 Mn |
| Jun 30, 2021 | -91.68 Mn |
| Mar 31, 2021 | 90.02 Mn |
| Dec 31, 2020 | 85.87 Mn |